U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Vaccines, Blood & Biologics
  3. Cellular & Gene Therapy Products
  4. ANDEXXA
  1. Cellular & Gene Therapy Products

ANDEXXA

STN: BLA 125586
Proper Name: coagulation factor Xa (recombinant), inactivated-zhzo
Trade Name: ANDEXXA
Manufacturer: AstraZeneca AB
Indication:

  • Indicated for patients treated with rivaroxaban and apixaban, when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.

Product Information

Supporting Documents

Back to Top